Keywords: jerini, merck, kgaa, sign, cancer, deal, germany

Jerini and Merck KGaA sign cancer deal

Article | 02 February 2004

Print This

Germany's Jerini AG and Merck KGaA have entered into a collaboration to develop small-molecule inhibitors against an undisclosed target for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in